Mirabegron (YM178)

CAS# 223673-61-8

Mirabegron (YM178)

Catalog No. BCC3814----Order now to get a substantial discount!

Product Name & Size Price Stock
Mirabegron (YM178): 5mg $150 In Stock
Mirabegron (YM178): 10mg Please Inquire In Stock
Mirabegron (YM178): 20mg Please Inquire Please Inquire
Mirabegron (YM178): 50mg Please Inquire Please Inquire
Mirabegron (YM178): 100mg Please Inquire Please Inquire
Mirabegron (YM178): 200mg Please Inquire Please Inquire
Mirabegron (YM178): 500mg Please Inquire Please Inquire
Mirabegron (YM178): 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Mirabegron (YM178)

Number of papers citing our products

Chemical structure

Mirabegron (YM178)

3D structure

Chemical Properties of Mirabegron (YM178)

Cas No. 223673-61-8 SDF Download SDF
PubChem ID 9865528 Appearance Powder
Formula C21H24N4O2S M.Wt 396.51
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : 100 mg/mL (252.20 mM; Need ultrasonic)
Chemical Name 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide
SMILES C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
Standard InChIKey PBAPPPCECJKMCM-IBGZPJMESA-N
Standard InChI InChI=1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Mirabegron (YM178) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Mirabegron (YM178) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Mirabegron (YM178)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.522 mL 12.61 mL 25.22 mL 50.4401 mL 63.0501 mL
5 mM 0.5044 mL 2.522 mL 5.044 mL 10.088 mL 12.61 mL
10 mM 0.2522 mL 1.261 mL 2.522 mL 5.044 mL 6.305 mL
50 mM 0.0504 mL 0.2522 mL 0.5044 mL 1.0088 mL 1.261 mL
100 mM 0.0252 mL 0.1261 mL 0.2522 mL 0.5044 mL 0.6305 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Mirabegron (YM178)

Mirabegron activates the β3 adrenergic receptor in the detrusor muscle in the bladder, which leads to muscle relaxation and an increase in bladder capacity.

Featured Products
New Products
 

References on Mirabegron (YM178)

Absorption, metabolism and excretion of [(14)C]mirabegron (YM178), a potent and selective beta(3)-adrenoceptor agonist, after oral administration to healthy male volunteers.[Pubmed:22269146]

Drug Metab Dispos. 2012 Apr;40(4):815-24.

The mass balance and metabolite profiles of 2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)[ U-(14)C]phenyl]acetamide ([(14)C]mirabegron, YM178), a beta(3)-adrenoceptor agonist for the treatment of overactive bladder, were characterized in four young, healthy, fasted male subjects after a single oral dose of [(14)C]mirabegron (160 mg, 1.85 MBq) in a solution. [(14)C]Mirabegron was rapidly absorbed with a plasma t(max) for mirabegron and total radioactivity of 1.0 and 2.3 h postdose, respectively. Unchanged mirabegron was the most abundant component of radioactivity, accounting for approximately 22% of circulating radioactivity in plasma. Mean recovery in urine and feces amounted to 55 and 34%, respectively. No radioactivity was detected in expired air. The main component of radioactivity in urine was unchanged mirabegron, which accounted for 45% of the excreted radioactivity. A total of 10 metabolites were found in urine. On the basis of the metabolites found in urine, major primary metabolic reactions of mirabegron were estimated to be amide hydrolysis (M5, M16, and M17), accounting for 48% of the identified metabolites in urine, followed by glucuronidation (M11, M12, M13, and M14) and N-dealkylation or oxidation of the secondary amine (M8, M9, and M15), accounting for 34 and 18% of the identified metabolites, respectively. In feces, the radioactivity was recovered almost entirely as the unchanged form. Eight of the metabolites characterized in urine were also observed in plasma. These findings indicate that mirabegron, administered as a solution, is rapidly absorbed after oral administration, circulates in plasma as the unchanged form and metabolites, and is recovered in urine and feces mainly as the unchanged form.

Description

Mirabegron is a selective β3-adrenoceptor agonist with EC50 of 22.4 nM.

Keywords:

Mirabegron (YM178),223673-61-8,Natural Products,Adrenergic Receptor, buy Mirabegron (YM178) , Mirabegron (YM178) supplier , purchase Mirabegron (YM178) , Mirabegron (YM178) cost , Mirabegron (YM178) manufacturer , order Mirabegron (YM178) , high purity Mirabegron (YM178)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: